Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ANADYS PHARMACEUTICALS INC | 25,000 | reported | 22 Aug 2011 | tx 1+25,000 |
| Dyne Therapeutics, Inc. | 20,000 | reported | 26 May 2026 | tx 5+79,500 |
| BIOGEN INC. | 8,025 | reported | 07 Jun 2022 | tx 48+115,085−107,084 |
| LMP CAPITAL & INCOME FUND INC. | 5,000 | reported | 11 Oct 2006 | tx 1+5,000 |
| BG Medicine, Inc. | 4,205 | reported | 03 Jun 2014 | tx 5+36,820 |
| Bioverativ Inc. | 0 | reported | 08 Mar 2018 | tx 13+69,962−42,855 |
| ARCH CAPITAL GROUP LTD. | 0 | reported | 11 May 2026 | tx 49+83,941−18,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 May 2026 | PURCHASE | Dyne Therapeutics, Inc. | 2,000 | 18.21 USD | |
| 20 May 2026 | PURCHASE | Dyne Therapeutics, Inc. | 2,500 | 17.12 USD | |
| 11 May 2026 | SALE | ARCH CAPITAL GROUP LTD. | 2,000 | 17.14 USD | |
| 05 May 2026 | GRANT_AWARD | ARCH CAPITAL GROUP LTD. | 2,071 | — | |
| 11 Mar 2026 | PURCHASE | Dyne Therapeutics, Inc. | 2,000 | 19.35 USD | |
| 11 Mar 2026 | SALE | ARCH CAPITAL GROUP LTD. | 3,000 | 17.12 USD | |
| 06 Mar 2026 | PURCHASE | Dyne Therapeutics, Inc. | 3,000 | 15.06 USD | |
| 01 Oct 2025 | GRANT_AWARD | Dyne Therapeutics, Inc. | 70,000 | 0.00 USD | deriv |
| 01 Aug 2025 | PURCHASE | ARCH CAPITAL GROUP LTD. | 1,000 | 17.34 USD | first after silence |
| 07 May 2025 | GRANT_AWARD | ARCH CAPITAL GROUP LTD. | 1,564 | — | |
| 09 May 2024 | GRANT_AWARD | ARCH CAPITAL GROUP LTD. | 1,455 | — | |
| 04 May 2023 | GRANT_AWARD | ARCH CAPITAL GROUP LTD. | 1,714 | — | |
| 07 Jun 2022 | GIFT | BIOGEN INC. | 150 | 0.00 USD | |
| 28 Oct 2022 | PURCHASE | ARCH CAPITAL GROUP LTD. | 2,000 | 17.60 USD | |
| 04 May 2022 | GRANT_AWARD | ARCH CAPITAL GROUP LTD. | 2,642 | — | |
| 04 May 2022 | GRANT_AWARD | ARCH CAPITAL GROUP LTD. | 2,642 | — | |
| 29 Apr 2022 | PURCHASE | ARCH CAPITAL GROUP LTD. | 2,000 | 19.23 USD | first after silence |
| 30 Sept 2021 | OTHER | ARCH CAPITAL GROUP LTD. | 2,000 | 25.00 USD | |
| 01 Jul 2021 | GRANT_AWARD | BIOGEN INC. | 775 | 0.00 USD | |
| 14 Jun 2021 | SALE | ARCH CAPITAL GROUP LTD. | 4,000 | 25.24 USD | |
| 04 Jun 2021 | SALE | BIOGEN INC. | 360 | 274.17 USD | |
| 06 May 2021 | GRANT_AWARD | ARCH CAPITAL GROUP LTD. | 3,143 | — | |
| 06 May 2021 | GRANT_AWARD | ARCH CAPITAL GROUP LTD. | 3,143 | — | |
| 03 Aug 2020 | GIFT | BIOGEN INC. | 125 | 0.00 USD | |
| 03 Jun 2020 | GRANT_AWARD | BIOGEN INC. | 890 | 0.00 USD |
5 purchases reported after at least 12 months of silence — most recent on 01 Aug 2025.